SPIAH-Q: Social-Psychological Intervention to Improve Adherence to HAART
Study Details
Study Description
Brief Summary
All eligible patients will be invited to use electronic monitoring of medication (MEMS) during the next six months. After two months with MEMS the enrolled patients will be randomized to intervention group or to control group. The intervention group will be submitted to four social-psycho sessions with a pre-trained health professional. The control group will receive the usual care of the health service.
The study will compare the rate of adherence to antiretroviral therapy between the intervention group and the control group. The duration of the study will be of six months. The analysis will be based on "intention-to-treat.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Intervention The intervention group will be submitted to four social-psychological individual sessions with a pre-trained health professional. |
Behavioral: Social-psycho intervention to improve adherence to HAART
The intervention focus on the notion of scenes and scenarios to examine and discussing the experience of taking ARV medicines. In principle, such an approach provides a tool for conscientization, action and the invention of novel group and individual repertoires that may result in individual mobilization for improving adherence to treatment and reducing his/her vulnerability.
|
Other: Control The control group will be submitted to the usual care of the health service. |
Other: Usual care
The control group will be submitted to the usual care of the health service
|
Outcome Measures
Primary Outcome Measures
- Adherence to HAART [24 weeks]
Secondary Outcome Measures
- Viral Load [12 and 24 weeks]
Eligibility Criteria
Criteria
Inclusion Criteria:
- Patients aged more than 18 years old, with detectable viral load and more than six months under HAART
Exclusion Criteria:
-
Pregnant women
-
Patients participating in other trials
-
Patients in treatment for hepatitis and for active opportunistic infection
-
Patients with mental or physical condition which do not allow their attendance to the health service
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Centro de Referência e Treinamento DST/AIDS | Sao Paulo | Brazil | 04121-000 |
Sponsors and Collaborators
- University of Sao Paulo
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Investigators
- Principal Investigator: Maria Ines B Nemes, PhD, Faculty of Medicine -University of Sao Paulo
- Study Director: Ernani T Santa Helena, PhD, Regional University of Blumenau
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- FAPESP 2006-61277-6